JS

Jayanti Swain

Active Director Director DIN 11800585
DIN 11800585 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayanti Swain

Jayanti Swain is a Director at Canwin Cancer Care Private Limited (since 2026).

DIN 11800585
Primary Designation Director
First Appointment 02 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Canwin Cancer Care Private Limited U86201OD2026PTC054418
Director02 Jul 20262026Active

Board colleagues of Jayanti Swain

NameDINCompanyDesignation
Abinash Patnaik11800587Canwin Cancer Care Private LimitedDirector
Aditya Misra11800586Canwin Cancer Care Private LimitedDirector
Rajalaxmi SahooCanwin Cancer Care Private LimitedIndividual Subscriber

Directorship timeline

Open interactive timeline →
Canwin Cancer Care Private Limited
Premium access

Shareholding and investment profile for Jayanti Swain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayanti Swain

Jayanti Swain currently holds 1 directorship: Canwin Cancer Care Private Limited (Director, since 02 Jul 2026).

Jayanti Swain was first appointed on 02 Jul 2026 as Director at Canwin Cancer Care Private Limited.

The current boards of Jayanti Swain's companies include Abinash Patnaik (Canwin Cancer Care Private Limited), Aditya Misra (Canwin Cancer Care Private Limited), Rajalaxmi Sahoo (Canwin Cancer Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available